BCR-ABL1 Transcript ≤10% IS an Early Molecular Response Predictor of Treatment-Free Remission Eligibility in Chronic Myeloid Leukemia

Rasekh EO et al. Clin Lymphoma Myeloma Leuk, April 2026 (epub ahead of print)

• Share
• Tweet
• Share
• Share